Direkt zum Inhalt
Merck
  • Osteogenic Differentiation of Human Adipose Tissue-Derived MSCs by Non-Toxic Calcium Poly(ethylene phosphate)s.

Osteogenic Differentiation of Human Adipose Tissue-Derived MSCs by Non-Toxic Calcium Poly(ethylene phosphate)s.

International journal of molecular sciences (2019-12-15)
Ilya Nifant'ev, Tatiana Bukharova, Alexander Dyakonov, Dmitry Goldshtein, Elena Galitsyna, Maxim Kosarev, Andrey Shlyakhtin, Dmitry Gavrilov, Pavel Ivchenko
ZUSAMMENFASSUNG

There is a current clinical need for the development of bone void fillers and bioactive bone graft substitutes. The use of mesenchymal stem cells (MSCs) that are seeded into 3D scaffolds and induce bone generation in the event of MSCs osteogenic differentiation is highly promising. Since calcium ions and phosphates promote the osteogenic differentiation of MSCs, the use of the calcium complexes of phosphate-containing polymers is highly prospective in the development of osteogenic scaffolds. Calcium poly(ethylene phosphate)s (PEP-Ca) appear to be potentially suitable candidates primarily because of PEP's biodegradability. In a series of experiments with human adipose-tissue-derived multipotent mesenchymal stem cells (ADSCs), we demonstrated that PEP-Ca are non-toxic and give rise to osteogenesis gene marker, bone morphogenetic protein 2 (BMP-2) and mineralization of the intercellular matrix. Owing to the synthetic availability of poly(ethylene phosphoric acid) block copolymers, these results hold out the possibility for the development of promising new polymer composites for orthopaedic and maxillofacial surgery.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
tert-Butanol, ≥99% (GC)
Sigma-Aldrich
DL-Glyceraldehyd-3-phosphat -Lösung, 45-55 mg/mL in H2O
Sigma-Aldrich
2,6-Difluoro-4-[2-(phenylsul­fonyl­amino)­ethyl­thio]­phenoxy­acet­amide, ≥98% (HPLC), solid